Daniel Skipper
@dcskipperdo
Husband. Dad. Private Practice Pathologist. Board certified in AP/CP, Cytopathology and Dermatopathology (MUSC).
ID: 4150180879
06-11-2015 21:28:21
3,3K Tweet
3,3K Takipçi
411 Takip Edilen
Even more spotters #pathboards for across the"board" Sarra Ben Rejeb Anna (Ania) B. Owczarczyk, MD PhD FASCP @AnnieMcLeanDMD Woo Cheal Cho, MD Olaleke Folaranmi Maryam Sayah, MD I Heart Pathology Katherina Baranova Prashant Bavi @pathnoob Adam L. Booth, MD Aishwarya Ravindran, MD Anna (Ania) B. Owczarczyk, MD PhD FASCP @AyshaMubeen86 @HermelinDaniela @pooja_dh_ Marina K Baine, MD, PhD
1. Thoracic and head-and-neck sites share many entities. Here is the latest one: Carcinomas with DEK::AFF2 fusions! This is a hot new entity in various ENT sites ... here is the first thoracic case! JTO & JTO CRR open access: authors.elsevier.com/a/1fJtY5Xq2QR5… J. Bish Frederic Askin MD
This is a nice resource! A deep-dive into IHC decision-making for tumors. Andrew Bellizzi 🇺🇦 An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin ncbi.nlm.nih.gov/pmc/articles/P…
“R/O Cyst” age 58. An aesthetic case with a Dx. Solitary lesion. Thanks to Tim McCalmont for discussing.
Etan Marks, DO @ArjunRamaiya1 Henry YANG David Terrano Christine J. Ko, MD Dermpath_doc_trish Daniel Skipper Jacob Smalberger, M.D. Tim McCalmont Jerad Gardner, MD We use the Ventana VE1 antibody. My impression is that is highly sensitive and specific for the BRAF V600E mutation. Other BRAF V600 mutations stain negatively. I once saw equivocal staining with it in a BRAF V600R-mutant melanoma in a cytology preparation:
I’m excited to share that the IHC update for #dermpath & #bstpath I wrote with Jerad Gardner, MD for Arch Pathol Lab Med is now available! 😁 You can read the full article here: meridian.allenpress.com/aplm/article/d… Have a great holiday weekend #pathtwitter / #pathX! 🔬🦠🧬